Anhui Huaheng Biotechnology Co., Ltd. (688639.SS)
- Previous Close
27.65 - Open
27.00 - Bid 27.08 x --
- Ask 27.10 x --
- Day's Range
26.81 - 27.48 - 52 Week Range
25.60 - 90.00 - Volume
1,702,871 - Avg. Volume
4,093,166 - Market Cap (intraday)
6.772B - Beta (5Y Monthly) -0.02
- PE Ratio (TTM)
40.42 - EPS (TTM)
0.67 - Earnings Date --
- Forward Dividend & Yield 0.90 (3.25%)
- Ex-Dividend Date Jul 22, 2024
- 1y Target Est
--
Anhui Huaheng Biotechnology Co., Ltd. engages in the development, production, and sale of amino acids and other organic acids in China and internationally. The company offers inositol, D-calcium pantothenate, L-valine, DL- alanine, L-citrulline, DL-malic acid, L-alanine, D-panthenol, L-citrulline DL-malate, L-malic acid, beta-alanine, a- arbutin, L-arginine, ß-arbutin, L-glycine, L-proline, amino acid concentrate, compound amino acid power, microbial inoculum, compound microbial fertilizer, and water soluble fertilizer products. Its products are used in daily chemical, medicine, health and personal care products, food additives, feeds, animal nutrition, plant nutrition, and functional nutrition. The company was formerly known as Anhui Huaheng Biological Engineering Co., Ltd. and changed its name to Anhui Huaheng Biotechnology Co., Ltd. in November 2013. The company was founded in 2005 and is based in Hefei, China.
www.huahengbio.comRecent News: 688639.SS
View MorePerformance Overview: 688639.SS
Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688639.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688639.SS
View MoreValuation Measures
Market Cap
6.90B
Enterprise Value
8.12B
Trailing P/E
41.27
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.73
Price/Book (mrq)
2.64
Enterprise Value/Revenue
3.43
Enterprise Value/EBITDA
40.09
Financial Highlights
Profitability and Income Statement
Profit Margin
6.93%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
2.37B
Net Income Avi to Common (ttm)
164.3M
Diluted EPS (ttm)
0.67
Balance Sheet and Cash Flow
Total Cash (mrq)
417.92M
Total Debt/Equity (mrq)
62.49%
Levered Free Cash Flow (ttm)
--